Literature DB >> 7264724

Opioid and non-opioid stress analgesia: assessment of tolerance and cross-tolerance with morphine.

J W Lewis, J E Sherman, J C Liebeskind.   

Abstract

Opioid and non-opioid mechanisms of analgesia elicited by two kinds of footshock stress that differ only in temporal characteristics previously have been inferred on the basis of susceptibility to naloxone blockade. The present study sought further evidence on this point by comparing these two kinds of footshock analgesia for possible tolerance development and cross-tolerance with morphine. It was found that, with repeated exposure to stress, tolerance developed to naloxone-sensitive, but not naloxone-insensitive, stress analgesia. Furthermore, morphine-tolerant rats displayed cross-tolerance to only the naloxone-sensitive form of footshock analgesia. Although prior exposure to both footshock paradigms potentiated morphine analgesia, less potentiation occurred in rats tolerant to the naloxone-sensitive footshock stress. Thus, cross-tolerance between morphine and this type of stress analgesia appears to occur in both directions. These findings are consistent with those using naloxone antagonism as a criterion for opioid mediation and support the conclusion that separate opioid and non-opioid mechanisms of stress analgesia exist.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7264724      PMCID: PMC6564135     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  13 in total

1.  Shared mechanisms for opioid tolerance and a transition to chronic pain.

Authors:  Elizabeth K Joseph; David B Reichling; Jon D Levine
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

2.  Stress-induced analgesia and endogenous opioid peptides: the importance of stress duration.

Authors:  Drupad Parikh; Abdul Hamid; Theodore C Friedman; Khanh Nguyen; Andy Tseng; Paul Marquez; Kabirullah Lutfy
Journal:  Eur J Pharmacol       Date:  2010-10-31       Impact factor: 4.432

3.  First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo.

Authors:  Kaidi Zhou; Jibran Y Khokhar; Bin Zhao; Rachel F Tyndale
Journal:  Biochem Pharmacol       Date:  2013-04-23       Impact factor: 5.858

4.  Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice.

Authors:  Camron D Bryant; Kristofer W Roberts; Janet S Byun; Michael S Fanselow; Christopher J Evans
Journal:  Pharmacol Biochem Behav       Date:  2006-12-28       Impact factor: 3.533

5.  Prior stress attenuates the analgesic response but sensitizes the corticosterone and cortical dopamine responses to stress 10 days later.

Authors:  A R Caggiula; S M Antelman; E Aul; S Knopf; D J Edwards
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice.

Authors:  A Köster; A Montkowski; S Schulz; E M Stübe; K Knaudt; F Jenck; J L Moreau; H P Nothacker; O Civelli; R K Reinscheid
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

7.  Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia.

Authors:  Richard L Suplita; Sarah A Eisenstein; Mark H Neely; Anna M Moise; Andrea G Hohmann
Journal:  Neuropharmacology       Date:  2007-07-19       Impact factor: 5.250

8.  Repeated restraint stress reduces opioid receptor binding in different rat CNS structures.

Authors:  Giovana Dantas; Iraci Lucena Da Silva Torres; Leonardo Machado Crema; Diogo R Lara; Carla Dalmaz
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

Review 9.  Classical conditioning and pain: conditioned analgesia and hyperalgesia.

Authors:  Gonzalo Miguez; Mario A Laborda; Ralph R Miller
Journal:  Acta Psychol (Amst)       Date:  2013-11-22

10.  Dexamethasone and stress-induced analgesia.

Authors:  S Mousa; C H Miller; D Couri
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.